Myeloma proteins as tumor-specific transplantation antigens
about
Immunogenic targets for specific immunotherapy in multiple myelomaImmunotherapy strategies for multiple myeloma: the present and the futureA novel mouse model for multiple myeloma (MOPC315.BM) that allows noninvasive spatiotemporal detection of osteolytic diseaseAutologous lymphoma vaccines induce human T cell responses against multiple, unique epitopes.Vaccines in oncology: background and clinical potential.Cell-bound myeloma proteins on the surface of myeloma cells: potential targets for the immune systemCell-free translation of immunoglobulin messenger RNA from MOPC-315 plasmacytoma and MOPC-315 NR, a variant synthesizing only light chainDendritic cells purified from myeloma are primed with tumor-specific antigen (idiotype) and activate CD4+ T cells.Localization of idiotypic antigenic determinants in the Fv region of murine myeloma protein MOPC-315.Vaccination with patient-specific tumor-derived antigen in first remission improves disease-free survival in follicular lymphomaDendritic cell-based immunotherapy for the treatment of hematological malignancies.Towards an off-the-shelf vaccine therapy targeting shared B-cell tumor idiotypes.Naive idiotype-specific CD4+ T cells and immunosurveillance of B-cell tumors.Dendritic cell-based immunotherapy in multiple myeloma.Th1/Th2 cells in patients with multiple myeloma.Idiotype vaccines in the treatment of B-cell non-Hodgkin's lymphoma.Rous-Whipple Award lecture. The biology and pathology of lymphocyte Fc receptorsTherapeutic idiotype vaccines in B lymphoproliferative diseases.Effect of solubilized membrane antigens and tumour bearer serum on tumour growth in syngeneic hosts.Induction of resistance or enhancement to a transplantable murine plasmacytoma by transfer of non-immune leucocytes.A vaccine directed to B cells and produced by cell-free protein synthesis generates potent antilymphoma immunityDNA vaccines, electroporation and their applications in cancer treatmentProtective and cellular immune responses to idiotypic determinants on cells from a spontaneous lymphoma of NZB-NZW F1 miceA small hypervariable segment in the variable domain of an immunoglobulin light chain stimulates formation of anti-idiotypic suppressor T cells.Neoantigen and tumor antigen-specific immunity transferred from immunized donors is detectable early after allogeneic transplantation in myeloma patients.Control of immunoglobulin secretion in the murine plasmacytoma line MOPC 315.Immunoregulation of murine myeloma in vitro. II. Suppression of MOPC-315 immunoglobulin secretion and synthesis by idiotype-specific suppressor T cellsSuppression of in vivo tumor formation induced by simian virus 40-transformed cells in mice receiving antiidiotypic antibodies.Syngeneic antiidiotypic immune responses to a B cell lymphoma. Comparison between heavy chain hypervariable region peptides and intact Ig as immunogens.Presence of clonal T cell populations in chronic B lymphocytic leukemia and smoldering myeloma.Anti-idiotype sera raised against surface immunoglobulin of human neoplastic lymphocytesComponents of immune function studied with lymphoid tumors.Epstein-Barr virus-encoded dUTPase enhances proinflammatory cytokine production by macrophages in contact with endothelial cells: evidence for depression-induced atherosclerotic risk.Trial watch: Peptide vaccines in cancer therapyTherapeutic lymphoma vaccines: importance of T-cell immunity.BiovaxID: a personalized therapeutic cancer vaccine for non-Hodgkin's lymphoma.Mechanisms of action of immune tolerance induction against factor VIII in patients with congenital haemophilia A and factor VIII inhibitors.Therapeutic vaccine for lymphoma.Development of orally active inhibitors of protein and cellular fucosylationBiovaxID idiotype vaccination: active immunotherapy for follicular lymphoma.
P2860
Q26859007-22D04C2A-27EA-4A10-922A-628A3129798DQ27021939-61D58D7E-622C-4D74-83BE-13FB87EC59F9Q27329429-95BA2A07-6244-4FA8-8353-DDADC57DF0B7Q33785039-EFDBC730-B9B0-45D3-AC64-7C039FFEE838Q34439914-48C6DD8A-DFF3-47AE-9E2D-F6020F9F5493Q34722592-8E9C8BE4-108C-474F-99EE-FA75276A44C1Q35067105-EF58EF79-B1E6-46BA-8184-7486CECC388EQ35079386-0C90930B-351F-4511-8D0D-995B31DCC5B1Q35104724-37AAE438-E5E1-457D-9E40-3ACB5DE5B444Q35114545-319004A1-F772-4D72-AC3F-C4A83871266CQ35127001-0868138F-ABF3-47D4-8E21-8D8463B9EE48Q35144751-661CF8B1-8EC1-4B58-B8C9-B349D54A9813Q35525622-BA89F85C-F0D8-4747-871E-CCA8906D9026Q35665926-91619DA9-6B3C-435D-A3E7-3B2523AACB05Q35668682-8C850076-240A-48DE-AF40-5055993C22A3Q35740264-AB31BEDF-BE4E-4177-AF85-2F70DBA7104EQ35765095-83FAB53D-C356-42C2-90BD-8BA9F7C0AAACQ35790890-3C14EDC9-C75B-4718-A0B4-6C95F37DC816Q36041211-6735047D-7E7A-457B-B91E-FE0A5035F989Q36068785-9DC5C013-901D-4C6D-A428-B8342A74F7BCQ36221727-D8B69A91-B46A-4BE9-A3E7-10EEF4C5D41BQ36256459-18CCB811-9DCF-4EC7-BAB3-0840EE192EE6Q36273765-7C396803-BC16-4E7D-A528-4C7AE8F25982Q36311069-30B4C5D5-631A-4120-ADA9-DFAAE90B404AQ36312922-8777FC70-EE89-42CE-A9DC-FD20D24D400EQ36341687-8B330A06-1964-45DF-93E8-74AEB2444908Q36346219-A94764DA-9283-4D94-B001-0CF0B109570FQ36350167-1F775F44-A821-4710-A2E7-9E2D77A4F8BDQ36350351-26077462-4A71-4C11-96DC-EEB8F55BD24AQ36350676-50F4F5B9-FF16-46D3-A6DE-AADDB56318E3Q36359921-11000F46-B36D-422C-B548-7DCBF52C08F8Q36448825-D4062CFE-6DA8-4C2C-BD7C-8D6C8729A6E5Q36464484-A8F1DBE3-23A3-4DAB-9F6E-AEA2BDF0D988Q36476100-A62B3F80-1B67-4D8D-8F93-203DEC4BAAE6Q36530231-E94BBC25-A704-498E-991B-5735D8887E47Q36675461-D13058F7-8BC2-4B0A-AAD6-8E84767CC6F1Q36707550-496CAB74-3822-4B5E-9755-DF6E271C6CD1Q36746586-4D462571-C77D-4987-BCF4-B678A908DE16Q36747458-9A454B10-EDA0-424D-9679-0E5D256C2B78Q36837124-5190E051-6FCB-4ECC-B41D-049028472246
P2860
Myeloma proteins as tumor-specific transplantation antigens
description
1972 nî lūn-bûn
@nan
1972 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
1972 թվականի հունիսին հրատարակված գիտական հոդված
@hy
1972年の論文
@ja
1972年論文
@yue
1972年論文
@zh-hant
1972年論文
@zh-hk
1972年論文
@zh-mo
1972年論文
@zh-tw
1972年论文
@wuu
name
Myeloma proteins as tumor-specific transplantation antigens
@ast
Myeloma proteins as tumor-specific transplantation antigens
@en
Myeloma proteins as tumor-specific transplantation antigens
@nl
type
label
Myeloma proteins as tumor-specific transplantation antigens
@ast
Myeloma proteins as tumor-specific transplantation antigens
@en
Myeloma proteins as tumor-specific transplantation antigens
@nl
prefLabel
Myeloma proteins as tumor-specific transplantation antigens
@ast
Myeloma proteins as tumor-specific transplantation antigens
@en
Myeloma proteins as tumor-specific transplantation antigens
@nl
P2093
P2860
P356
P1476
Myeloma proteins as tumor-specific transplantation antigens
@en
P2093
P2860
P304
P356
10.1073/PNAS.69.6.1540
P407
P577
1972-06-01T00:00:00Z